Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body€™s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
Market Analysis and Insights: Global Anti-Ageing Drugs Market
The global Anti-Ageing Drugs market size is projected to reach US$ 140690 million by 2027, from US$ 91160 million in 2020, at a CAGR of 7.5% during 2021-2027.
Global Anti-Ageing Drugs Scope and Segment
The global Anti-Ageing Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Ageing Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
By the end users/application, this report covers the following segments
Skin
Hair
Others
Competitive Landscape:
The report provides a list of all the key players in the Anti-Ageing Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anti-Ageing Drugs key manufacturers in this market include:
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Market Analysis and Insights: Global Anti-Ageing Drugs Market
The global Anti-Ageing Drugs market size is projected to reach US$ 140690 million by 2027, from US$ 91160 million in 2020, at a CAGR of 7.5% during 2021-2027.
Global Anti-Ageing Drugs Scope and Segment
The global Anti-Ageing Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Ageing Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
By the end users/application, this report covers the following segments
Skin
Hair
Others
Competitive Landscape:
The report provides a list of all the key players in the Anti-Ageing Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anti-Ageing Drugs key manufacturers in this market include:
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
1 Anti-Ageing Drugs Market Overview
1.1 Anti-Ageing Drugs Product Overview
1.2 Anti-Ageing Drugs Market Segment by Type
1.2.1 Hormonal Therapy
1.2.2 Antioxidants
1.2.3 Enzymes
1.2.4 Stem Cells
1.2.5 Others
1.3 Global Anti-Ageing Drugs Market Size by Type
1.3.1 Global Anti-Ageing Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Anti-Ageing Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anti-Ageing Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anti-Ageing Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anti-Ageing Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anti-Ageing Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anti-Ageing Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
2 Global Anti-Ageing Drugs Market Competition by Company
2.1 Global Top Players by Anti-Ageing Drugs Sales (2016-2021)
2.2 Global Top Players by Anti-Ageing Drugs Revenue (2016-2021)
2.3 Global Top Players Anti-Ageing Drugs Price (2016-2021)
2.4 Global Top Manufacturers Anti-Ageing Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Ageing Drugs Market Competitive Situation and Trends
2.5.1 Anti-Ageing Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Ageing Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Anti-Ageing Drugs Market
2.8 Key Manufacturers Anti-Ageing Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Ageing Drugs Status and Outlook by Region
3.1 Global Anti-Ageing Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anti-Ageing Drugs Historic Market Size by Region
3.2.1 Global Anti-Ageing Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Anti-Ageing Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Anti-Ageing Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anti-Ageing Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Ageing Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Anti-Ageing Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Anti-Ageing Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anti-Ageing Drugs by Application
4.1 Anti-Ageing Drugs Market Segment by Application
4.1.1 Skin
4.1.2 Hair
4.1.3 Others
4.2 Global Anti-Ageing Drugs Market Size by Application
4.2.1 Global Anti-Ageing Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Anti-Ageing Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anti-Ageing Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anti-Ageing Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anti-Ageing Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anti-Ageing Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anti-Ageing Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
5 North America Anti-Ageing Drugs by Country
5.1 North America Anti-Ageing Drugs Historic Market Size by Country
5.1.1 North America Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Anti-Ageing Drugs Sales in Value by Country (2016-2021)
5.2 North America Anti-Ageing Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Anti-Ageing Drugs Sales in Value by Country (2022-2027)
6 Europe Anti-Ageing Drugs by Country
6.1 Europe Anti-Ageing Drugs Historic Market Size by Country
6.1.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Anti-Ageing Drugs Sales in Value by Country (2016-2021)
6.2 Europe Anti-Ageing Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Anti-Ageing Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Anti-Ageing Drugs by Region
7.1 Asia-Pacific Anti-Ageing Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anti-Ageing Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2022-2027)
8 Latin America Anti-Ageing Drugs by Country
8.1 Latin America Anti-Ageing Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anti-Ageing Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Anti-Ageing Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anti-Ageing Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Anti-Ageing Drugs by Country
9.1 Middle East and Africa Anti-Ageing Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anti-Ageing Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anti-Ageing Drugs Business
10.1 Nu Skin
10.1.1 Nu Skin Corporation Information
10.1.2 Nu Skin Introduction and Business Overview
10.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Nu Skin Anti-Ageing Drugs Products Offered
10.1.5 Nu Skin Recent Development
10.2 BIOTIME
10.2.1 BIOTIME Corporation Information
10.2.2 BIOTIME Introduction and Business Overview
10.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Nu Skin Anti-Ageing Drugs Products Offered
10.2.5 BIOTIME Recent Development
10.3 Elysium Health
10.3.1 Elysium Health Corporation Information
10.3.2 Elysium Health Introduction and Business Overview
10.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Elysium Health Anti-Ageing Drugs Products Offered
10.3.5 Elysium Health Recent Development
10.4 La Roche-Posay
10.4.1 La Roche-Posay Corporation Information
10.4.2 La Roche-Posay Introduction and Business Overview
10.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 La Roche-Posay Anti-Ageing Drugs Products Offered
10.4.5 La Roche-Posay Recent Development
10.5 DermaFix
10.5.1 DermaFix Corporation Information
10.5.2 DermaFix Introduction and Business Overview
10.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 DermaFix Anti-Ageing Drugs Products Offered
10.5.5 DermaFix Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Ageing Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Ageing Drugs Industrial Chain Analysis
11.4 Anti-Ageing Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Ageing Drugs Distributors
12.3 Anti-Ageing Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Anti-Ageing Drugs Product Overview
1.2 Anti-Ageing Drugs Market Segment by Type
1.2.1 Hormonal Therapy
1.2.2 Antioxidants
1.2.3 Enzymes
1.2.4 Stem Cells
1.2.5 Others
1.3 Global Anti-Ageing Drugs Market Size by Type
1.3.1 Global Anti-Ageing Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Anti-Ageing Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anti-Ageing Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anti-Ageing Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anti-Ageing Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anti-Ageing Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anti-Ageing Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Type (2016-2021)
2 Global Anti-Ageing Drugs Market Competition by Company
2.1 Global Top Players by Anti-Ageing Drugs Sales (2016-2021)
2.2 Global Top Players by Anti-Ageing Drugs Revenue (2016-2021)
2.3 Global Top Players Anti-Ageing Drugs Price (2016-2021)
2.4 Global Top Manufacturers Anti-Ageing Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Ageing Drugs Market Competitive Situation and Trends
2.5.1 Anti-Ageing Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Ageing Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Anti-Ageing Drugs Market
2.8 Key Manufacturers Anti-Ageing Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Ageing Drugs Status and Outlook by Region
3.1 Global Anti-Ageing Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anti-Ageing Drugs Historic Market Size by Region
3.2.1 Global Anti-Ageing Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Anti-Ageing Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Anti-Ageing Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anti-Ageing Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Ageing Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Anti-Ageing Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Anti-Ageing Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anti-Ageing Drugs by Application
4.1 Anti-Ageing Drugs Market Segment by Application
4.1.1 Skin
4.1.2 Hair
4.1.3 Others
4.2 Global Anti-Ageing Drugs Market Size by Application
4.2.1 Global Anti-Ageing Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Anti-Ageing Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anti-Ageing Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anti-Ageing Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anti-Ageing Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anti-Ageing Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anti-Ageing Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anti-Ageing Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Application (2016-2021)
5 North America Anti-Ageing Drugs by Country
5.1 North America Anti-Ageing Drugs Historic Market Size by Country
5.1.1 North America Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Anti-Ageing Drugs Sales in Value by Country (2016-2021)
5.2 North America Anti-Ageing Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Anti-Ageing Drugs Sales in Value by Country (2022-2027)
6 Europe Anti-Ageing Drugs by Country
6.1 Europe Anti-Ageing Drugs Historic Market Size by Country
6.1.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Anti-Ageing Drugs Sales in Value by Country (2016-2021)
6.2 Europe Anti-Ageing Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Anti-Ageing Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Anti-Ageing Drugs by Region
7.1 Asia-Pacific Anti-Ageing Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anti-Ageing Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2022-2027)
8 Latin America Anti-Ageing Drugs by Country
8.1 Latin America Anti-Ageing Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anti-Ageing Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Anti-Ageing Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anti-Ageing Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Anti-Ageing Drugs by Country
9.1 Middle East and Africa Anti-Ageing Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anti-Ageing Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anti-Ageing Drugs Business
10.1 Nu Skin
10.1.1 Nu Skin Corporation Information
10.1.2 Nu Skin Introduction and Business Overview
10.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Nu Skin Anti-Ageing Drugs Products Offered
10.1.5 Nu Skin Recent Development
10.2 BIOTIME
10.2.1 BIOTIME Corporation Information
10.2.2 BIOTIME Introduction and Business Overview
10.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Nu Skin Anti-Ageing Drugs Products Offered
10.2.5 BIOTIME Recent Development
10.3 Elysium Health
10.3.1 Elysium Health Corporation Information
10.3.2 Elysium Health Introduction and Business Overview
10.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Elysium Health Anti-Ageing Drugs Products Offered
10.3.5 Elysium Health Recent Development
10.4 La Roche-Posay
10.4.1 La Roche-Posay Corporation Information
10.4.2 La Roche-Posay Introduction and Business Overview
10.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 La Roche-Posay Anti-Ageing Drugs Products Offered
10.4.5 La Roche-Posay Recent Development
10.5 DermaFix
10.5.1 DermaFix Corporation Information
10.5.2 DermaFix Introduction and Business Overview
10.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 DermaFix Anti-Ageing Drugs Products Offered
10.5.5 DermaFix Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Ageing Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Ageing Drugs Industrial Chain Analysis
11.4 Anti-Ageing Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Ageing Drugs Distributors
12.3 Anti-Ageing Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
